Gables Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23K | Sell |
21
-15
| -42% | -$1.59K | ﹤0.01% | 408 |
|
|
2025
Q1 | $4.47K | Hold |
36
| – | – | ﹤0.01% | 392 |
|
|
2024
Q4 | $4.43K | Sell |
36
-1,293
| -97% | -$159K | ﹤0.01% | 394 |
|
|
2024
Q3 | $148K | Sell |
1,329
-830
| -38% | -$92.5K | 0.07% | 142 |
|
|
2024
Q2 | $230K | Sell |
2,159
-240
| -10% | -$25.6K | 0.12% | 109 |
|
|
2024
Q1 | $289K | Sell |
2,399
-100
| -4% | -$12K | 0.16% | 103 |
|
|
2023
Q4 | $307K | Hold |
2,499
| – | – | 0.19% | 95 |
|
|
2023
Q3 | $323K | Sell |
2,499
-82
| -3% | -$10.6K | 0.23% | 82 |
|
|
2023
Q2 | $320K | Sell |
2,581
-65
| -2% | -$8.06K | 0.21% | 88 |
|
|
2023
Q1 | $387K | Hold |
2,646
| – | – | 0.27% | 76 |
|
|
2022
Q4 | $422K | Hold |
2,646
| – | – | 0.31% | 71 |
|
|
2022
Q3 | $353K | Sell |
2,646
-135
| -5% | -$18K | 0.28% | 77 |
|
|
2022
Q2 | $434K | Sell |
2,781
-65
| -2% | -$10.1K | 0.33% | 71 |
|
|
2022
Q1 | $443K | Sell |
2,846
-50
| -2% | -$7.78K | 0.28% | 82 |
|
|
2021
Q4 | $369K | Buy |
2,896
+726
| +33% | +$92.5K | 0.22% | 93 |
|
|
2021
Q3 | $283K | Buy |
2,170
+1,643
| +312% | +$214K | 0.18% | 104 |
|
|
2021
Q2 | $94K | Buy |
+527
| New | +$94K | 0.06% | 154 |
|